Equatorial Guinea vs Europe (WHO region): Hepatitis B surface antigen (HBsAg) prevalence (%)
Equatorial Guinea
2.0%
in 2024
Europe (WHO region)
0.1%
in 2024
Equatorial Guinea rank
12th
Europe (WHO region) rank
10th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Equatorial Guinea
- Europe (WHO region)
How they compare
Equatorial Guinea currently reports 2.0% against 0.1% in Europe (WHO region), a difference of 1.9%.
That makes Equatorial Guinea's figure about 20.0 times Europe (WHO region)'s.
Across all 10 years both countries report, Equatorial Guinea has been ahead every year.
Equatorial Guinea ranks 12th and Europe (WHO region) ranks 10th of 194 countries.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.3% | 0.1% | 2.2% | Equatorial Guinea |
| 2020s | 2.1% | 0.1% | 2.0% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Equatorial Guinea or Europe (WHO region)?
- Equatorial Guinea, at 2.0% against 0.1% in Europe (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Equatorial Guinea and Europe (WHO region)?
- 1.9%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Europe (WHO region)?
- 10 years are reported by both, from 2015 to 2024.
- How do Equatorial Guinea and Europe (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Equatorial Guinea ranks 12th and Europe (WHO region) ranks 10th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.